She could decide to die with her own convictions intact
En una mañana de mayo en Montevideo, una mujer de 69 años eligió el momento y la forma de su muerte, convirtiéndose en el primer caso de eutanasia legal en la historia de Uruguay y en toda América Latina. Su decisión, tomada con plena conciencia y respaldada por un marco legal aprobado apenas meses antes, no fue solo un acto personal sino un hito en la larga conversación humana sobre la autonomía, el sufrimiento y la dignidad al final de la vida. Uruguay se une así a un pequeño grupo de naciones que han reconocido legalmente el derecho a morir, abriendo un camino que otros países de la región observan con atención.
- Una mujer con cáncer de páncreas terminal firmó su consentimiento el miércoles y murió el viernes: la urgencia de su deterioro no dejó margen para la demora.
- El primer caso legal sacudió a Uruguay y a América Latina, convirtiendo una ley abstracta en una realidad concreta e irreversible que divide opiniones sobre los límites de la medicina.
- El proceso exigió múltiples revisiones médicas, plazos formales y la posibilidad de retractarse en cualquier momento, mostrando que el Estado intentó equilibrar libertad individual con salvaguardas colectivas.
- El legislador Federico Preve celebró el día como simbólicamente trascendente, mientras Colombia y otros países de la región aceleran sus propios debates legislativos inspirados en el modelo uruguayo.
- Lo que queda abierto es la pregunta más difícil: cuántas personas recurrirán a esta ley, cómo responderá la comunidad médica, y si Uruguay se convertirá en el espejo en el que el resto de la región aprenda a mirarse.
Un viernes de mayo, una mujer de 69 años murió en el Hospital Policial de Montevideo tras recibir una inyección letal administrada por personal médico. Estaba consciente, había firmado los documentos y había elegido ese final. Era el primer caso de eutanasia legal en la historia de Uruguay.
Había llegado al hospital diez días antes con un cáncer de páncreas en etapa terminal. El miércoles firmó el consentimiento formal; el viernes, todo había concluido. El camino hasta ese momento comenzó en octubre de 2025, cuando el parlamento aprobó la ley, y se completó en abril de 2026, cuando el presidente Yamandú Orsi firmó el decreto reglamentario que la puso en vigor. Uruguay se convirtió así en el primer país de América Latina en legalizar la práctica, uniéndose a Países Bajos, Bélgica, Luxemburgo, Canadá, España, Nueva Zelanda y Portugal.
La ley establece requisitos precisos: el paciente debe ser adulto, ciudadano o residente legal, mentalmente competente, y padecer una enfermedad terminal incurable que cause sufrimiento insoportable. El proceso incluye múltiples controles: un médico recibe la solicitud y tiene tres días para responder; un segundo especialista revisa el caso; si hay desacuerdo, una junta médica decide. En cualquier momento, el paciente puede cambiar de opinión sin dar explicaciones.
El legislador Federico Preve calificó el día como simbólicamente importante, destacando que esta mujer pudo decidir cómo morir, eligiendo un final coherente con sus propias convicciones. Mientras tanto, Colombia —que despenalizó la eutanasia en 1997 y amplió su alcance en 2022— aún no ha redactado las regulaciones necesarias para hacerla operativa. Otros países de la región observan de cerca cómo funciona el marco uruguayo, dónde surgen fricciones y qué salvaguardas resisten la prueba de la realidad.
On a Friday morning in May, a 69-year-old woman died at the Police Hospital in Montevideo after receiving a lethal injection administered by medical staff. She was conscious, she had signed the papers, and she had chosen this ending. It was the first legal euthanasia in Uruguay's history.
The woman had arrived at the hospital ten days earlier, her condition deteriorating rapidly. She was dying of pancreatic cancer—the kind that does not stop, does not slow, does not negotiate. By Wednesday, she had made her decision and signed the formal consent. Two days later, it was done.
Uruguay's path to this moment began in October 2025, when lawmakers passed a euthanasia law. The legislation sat unsigned until April 2026, when President Yamandú Orsi issued the regulatory decree that brought it into force. The country became the first in Latin America to legalize the practice, joining a small international club: the Netherlands, Belgium, Luxembourg, Canada, Spain, New Zealand, and Portugal.
The law itself is precise about who qualifies. A patient must be an adult, a citizen or legal resident, mentally competent, and suffering from a terminal illness that cannot be cured and causes unbearable pain or severe degradation of life. The process involves multiple checkpoints. A physician receives the request and has three days to respond. A second doctor—an internist or specialist—then reviews the case. If both agree the criteria are met, the procedure moves forward. If they disagree, a medical board makes the final call. At any point, the patient can change their mind without explanation.
Federico Preve, one of the lawmakers who championed the legislation, called Friday "a symbolically important day" for Uruguay. He emphasized that this woman had been able to decide how she would die, to choose an ending that aligned with her own beliefs and values. For supporters of the law, the moment represented something fundamental: the right to control one's own death when suffering becomes intolerable and recovery is impossible.
The case arrives as other Latin American countries grapple with similar questions. Colombia decriminalized euthanasia in 1997 and expanded it in 2022 to include medical assistance in dying for people with grave or incurable illnesses. But Colombia has not yet written the specific regulations needed to make the law workable in practice. Other nations in the region are watching Uruguay's implementation closely, studying how the framework functions, where the friction points emerge, what safeguards hold and which ones bend.
For this woman and her family, the choice was made and the outcome is final. What remains is the question of what comes next—how many others will use this law, how the medical community will adapt to administering it, and whether Uruguay's model will become a template for the rest of the region.
Notable Quotes
This person was able to decide to die with tranquility, to choose to pass away according to her own convictions— Federico Preve, deputy and law supporter
The Hearth Conversation Another angle on the story
Why does this particular case matter so much? It's one person.
Because it's the first. It establishes that the law works, that the system can actually function as written. It also signals to other patients in similar situations that this option exists and is available to them.
What about the doctors involved? How do they feel about being asked to end a life?
The law builds in protections for them. They can refuse. They have time to think. And they're not alone—there's a second opinion, potentially a board. It's structured to prevent any single person from carrying the full weight of the decision.
Is there resistance to this in Uruguay itself?
The source doesn't say. But the fact that it took from October 2025 to April 2026 for the president to sign the decree suggests there may have been deliberation, perhaps negotiation. Laws don't always move quickly when they're controversial.
What about the woman's family? Do we know anything about them?
No. The reporting focuses on the legal and medical dimensions. Her family's experience, their feelings about her choice—that's not in the record. We know she decided. We don't know who stood with her.
So Uruguay is now part of a very small group of countries.
Yes. Seven others worldwide. And it's the first in its entire region. That's significant. It means other Latin American countries are now looking at Uruguay not as an abstract example but as a neighbor, a peer, a place where this actually happened.
What happens if the law gets abused? If doctors start pushing patients toward it?
The law has safeguards—multiple doctors, the patient's right to withdraw, the requirement that the illness be terminal and incurable. But whether those safeguards are enough, whether they hold up over time, that's something only practice will reveal.